MEGF10, a Glioma Survival-Associated Molecular Signature, Predicts IDH Mutation Status
Glioma is the most common primary brain tumor with various genetic alterations; among which, IDH mutation is the most common mutation and plays an important role in glioma early development, especially in lower grade glioma (LGG, WHO II-III). Previous studies have found that IDH mutation is tightly...
Main Authors: | Guanzhang Li, Zhiliang Wang, Chuanbao Zhang, Xing Liu, Fuqiang Yang, Lihua Sun, Jingshan Liang, Huimin Hu, Yanwei Liu, Gan You, Zhaoshi Bao, Wei Zhang, Zheng Wang, Tao Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2018/5975216 |
Similar Items
-
Molecular and clinical characterization of IDH associated immune signature in lower-grade gliomas
by: Zenghui Qian, et al.
Published: (2018-06-01) -
High-dose radiation associated with improved survival in IDH-wildtype low-grade glioma
by: Shuai Liu, et al.
Published: (2021-04-01) -
IDH gene mutation in glioma
by: Leping Liu, et al.
Published: (2018-01-01) -
Research progress of IDH1 and IDH2 mutations in gliomas
by: Shan-shan ZHANG, et al.
Published: (2015-11-01) -
Molecular and clinical characterization of TIM-3 in glioma through 1,024 samples
by: Guanzhang Li, et al.
Published: (2017-08-01)